PHILADELPHIA-CHROMOSOME POSITIVE B-CELL TYPE MALIGNANT-LYMPHOMA EXPRESSING AN ABERRANT 190 KDA BCR-ABL PROTEIN

Summary The Philadelphia (Ph) chromosome translocation, t(9:22) (q34;q11) is found in some acute lymphoid leukaemias (ALL) and acute myeloid leukaemias (AML). Although cytogenetically all Ph chromosomes appear similar, the 22q11 breakpoints found in acute leukaemias are of two kinds, those within the major breakpoint cluster region (Mbcr‐1) of the BCR gene as found in chronic myelogenous leukaemia (CML), and those within the first intron of this gene. In the former group the molecular events are the same as those found in CML, p210 bcr‐abl, encoded by 8.5 kb mRNA; however, a new aberrant protein, p190 bcr‐abl, is found in the latter group. Ph translocation is also found in a few cases with malignant lymphoma, but it has not been characterized at the molecular level. We describe here a non‐Hodgkin's lymphoma case with primary splenic presentation, which showed a complex Ph translocation. Neoplastic cells were of a B‐cell origin (HLA‐DR+, sIgM+, sIgΔ+, CALLA‐). Molecular studies revealed the expression of p190 bcr‐abl with no Mbcr‐1 rearrangement. Our case indicates that the same Ph translocation as seen in acute leukaemias can be found in hematologic disorders other than leukaemias, suggesting that a c‐abl gene activating mechanism may be involved in the pathogenesis of wide spectrum of haematologic malignancies. Copyright © 1990, Wiley Blackwell. All rights reserved